Pfizer Inc (PFE) Analyst Research| Reuters.com
Edition:
United States

Pfizer Inc (PFE)

PFE on New York Consolidated

35.01USD
29 Jun 2016
Change (% chg)

$0.57 (+1.66%)
Prev Close
$34.44
Open
$34.62
Day's High
$35.15
Day's Low
$34.57
Volume
24,864,130
Avg. Vol
39,823,057
52-wk High
$36.46
52-wk Low
$28.25

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Pfizer Inc (PFE-N) 29 Jun 2016 Thomson Reuters Stock Report 12 25.00
PFE: Due Diligence Review: Forensic Earnings and Valuation 28 Jun 2016 New Constructs, LLC 10 25.00
Wright Investors Service Comprehensive Report for Pfizer Inc. 26 Jun 2016 Wright Reports 62 75.00
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. 25 Jun 2016 Stock Traders Daily 12 20.00
ValuEngine Rating and Forecast Report for PFE 25 Jun 2016 ValuEngine, Inc. 11 25.00
Pfizer, Inc 25 Jun 2016 S&P Capital IQ – STARS Reports 11 127.00
Our Economy without Stimulus; forward observations. 24 Jun 2016 Stock Traders Daily 102 20.00
PFIZER INC (PFE=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 24 Jun 2016 Pechala's Reports 2 25.00
Pfizer Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Value Graph: PFIZER -- PFE 23 Jun 2016 Ford Investor Services, Inc. 1 12.00
 
Name Age Since Current Position

Ian Read

62 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

58 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

53 2016 Group President - Vaccines, Oncology and Consumer Healthcare Business, Global Innovative Pharma Business

Mikael Dolsten

57 2010 President - Worldwide Research and Development

John Young

51 2014 Group President - Global Established Pharma Business